Price $170.49 |
Market Cap
1.05B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
22.2
|
P/B
4.19
|
P/S
2.83
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
61.2
|
Op. Cash Flow
28.4K
|
FCF
2.3
|
|
Op. Margin
17.30%
|
Net Margin
12.90%
|
ROE
20.50%
|
ROI
15.20%
|
|
ROA
12.80%
|
EPS Growth
137.30%
|
Current Ratio
2.1
|
Debt/Equity
21.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, In (CPIX) | $1.68 | - | - | 28.7M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.15 | - | - | 4.1M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $121.45 | - | - | 8.13B | Strong Buy |
| Journey Medical Corp (DERM) | $4.97 | - | - | 43.3M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.37 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
